Lakshmi A Devi - Publications

pharmacological sciences Icahn School of Medicine at Mount Sinai, New York, NY, United States 

107 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Gupta A, Gullapalli S, Pan H, Ramos-Ortolaza DL, Hayward MD, Low MJ, Pintar JE, Devi LA, Gomes I. Regulation of Opioid Receptors by Their Endogenous Opioid Peptides. Cellular and Molecular Neurobiology. PMID 33389463 DOI: 10.1007/s10571-020-01015-w  1
2020 Fricker LD, Tashima AK, Fakira AK, Hochgeschwender U, Wetsel WC, Devi LA. Neuropeptidomic Analysis of a Genetically Defined Cell Type in Mouse Brain and Pituitary. Cell Chemical Biology. PMID 33217339 DOI: 10.1016/j.chembiol.2020.11.003  1
2020 Fakira AK, Devi LA, Kennedy PJ. Novel Application for G Protein-Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention. Biological Psychiatry. 88: 896-897. PMID 33213702 DOI: 10.1016/j.biopsych.2020.09.006  1
2020 Faouzi A, Uprety R, Gomes I, Massaly N, Keresztes AI, Le Rouzic V, Gupta A, Zhang T, Yoon HJ, Ansonoff M, Allaoa A, Pan YX, Pintar J, Morón JA, Streicher JM, ... Devi LA, et al. Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template. Journal of Medicinal Chemistry. PMID 33170687 DOI: 10.1021/acs.jmedchem.0c00901  1
2020 Palma JA, Gupta A, Sierra S, Gomes I, Balgobin B, Norcliffe-Kaufmann L, Devi LA, Kaufmann H. Autoantibodies blocking M muscarinic receptors cause postganglionic cholinergic dysautonomia. Annals of Neurology. PMID 32833276 DOI: 10.1002/ana.25882  1
2020 Fricker LD, Margolis E, Gomes I, Devi LA. Five decades of research on opioid peptides: Current knowledge and unanswered questions. Molecular Pharmacology. PMID 32487735 DOI: 10.1124/mol.120.119388  1
2020 Gomes I, Sierra S, Lueptow L, Gupta A, Gouty S, Margolis EB, Cox BM, Devi LA. Biased signaling by endogenous opioid peptides. Proceedings of the National Academy of Sciences of the United States of America. PMID 32393639 DOI: 10.1073/pnas.2000712117  1
2019 Sierra S, Gupta A, Gomes I, Fowkes M, Ram A, Bobeck EN, Devi LA. Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain. Acs Pharmacology & Translational Science. 2: 219-229. PMID 31565698 DOI: 10.1021/acsptsci.9b00008  1
2019 McDermott MV, Afrose L, Gomes I, Devi LA, Bobeck EN. Opioid-induced signaling and antinociception are modulated by the recently deorphanized receptor, GPR171. The Journal of Pharmacology and Experimental Therapeutics. PMID 31308196 DOI: 10.1124/jpet.119.259242  1
2019 Fakira AK, Peck EG, Liu Y, Lueptow LM, Trimbake NA, Han MH, Calipari ES, Devi LA. The role of the neuropeptide PEN receptor, GPR83, in the reward pathway: Relationship to sex-differences. Neuropharmacology. 107666. PMID 31199956 DOI: 10.1016/j.neuropharm.2019.107666  1
2019 Mack SM, Gomes I, Devi LA. Neuropeptide PEN and its receptor GPR83; Distribution, Signaling and Regulation. Acs Chemical Neuroscience. PMID 30726666 DOI: 10.1021/acschemneuro.8b00559  1
2018 Fujita W, Yokote M, Gomes I, Gupta A, Ueda H, Devi LA. Regulation of a opioid receptor chaperone protein, RTP4, by morphine. Molecular Pharmacology. PMID 30348895 DOI: 10.1124/mol.118.112987  1
2018 Lueptow LM, Devi LA, Fakira AK. Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders. Progress in Molecular Biology and Translational Science. 159: 1-25. PMID 30340784 DOI: 10.1016/bs.pmbts.2018.07.002  1
2018 Heimann AS, Gupta A, Gomes I, Rahman R, Schlessinger A, Ferro ES, Unterwald EM, Devi LA. Correction: Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states. Plos One. 13: e0193322. PMID 29447277 DOI: 10.1371/journal.pone.0193322  1
2017 Reckziegel P, Festuccia WT, Britto LRG, Jang KLL, Romão CM, Heimann JC, Fogaça MV, Rodrigues NS, Silva NR, Guimarães FS, Eichler RAS, Gupta A, Gomes I, Devi LA, Heimann AS, et al. A novel peptide that improves metabolic parameters without adverse central nervous system effects. Scientific Reports. 7: 14781. PMID 29093454 DOI: 10.1038/s41598-017-13690-9  1
2017 Heimann AS, Gupta A, Gomes I, Rayees R, Schlessinger A, Ferro ES, Unterwald EM, Devi LA. Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states. Plos One. 12: e0187306. PMID 29091950 DOI: 10.1371/journal.pone.0187306  1
2017 Margolis EB, Fujita W, Devi LA, Fields HL. Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor. Neuropharmacology. PMID 28645621 DOI: 10.1016/j.neuropharm.2017.06.019  1
2017 Bobeck EN, Gomes I, Pena D, Cummings KA, Clem RL, Mezei M, Devi LA. The BigLEN-GPR171 Peptide Receptor System within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28425495 DOI: 10.1038/npp.2017.79  1
2016 Gomes I, Sierra S, Devi LA. Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay. Current Protocols in Pharmacology. 75: 2.16.1-2.16.31. PMID 27960030 DOI: 10.1002/cpph.15  1
2016 Wardman JH, Gomes I, Bobeck EN, Stockert JA, Kapoor A, Bisignano P, Gupta A, Mezei M, Kumar S, Filizola M, Devi LA. Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake. Science Signaling. 9: ra55. PMID 27245612 DOI: 10.1126/scisignal.aac8035  1
2016 Gupta A, Gomes I, Bobeck EN, Fakira AK, Massaro NP, Sharma I, Cavé A, Hamm HE, Parello J, Devi LA. Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity. Proceedings of the National Academy of Sciences of the United States of America. PMID 27162327 DOI: 10.1073/pnas.1521825113  1
2016 Gomes I, Bobeck EN, Margolis EB, Gupta A, Sierra S, Fakira AK, Fujita W, Müller TD, Müller A, Tschöp MH, Kleinau G, Fricker LD, Devi LA. Identification of GPR83 as the receptor for the neuroendocrine peptide PEN. Science Signaling. 9: ra43. PMID 27117253 DOI: 10.1126/scisignal.aad0694  1
2016 Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA. G Protein-Coupled Receptor Heteromers. Annual Review of Pharmacology and Toxicology. 56: 403-25. PMID 26514203 DOI: 10.1146/annurev-pharmtox-011613-135952  1
2015 Stockton SD, Gomes I, Liu T, Moraje C, Hipólito L, Jones MR, Ma'ayan A, Morón JA, Li H, Devi LA. Morphine Regulated Synaptic Networks Revealed by Integrated Proteomics and Network Analysis. Molecular & Cellular Proteomics : McP. PMID 26149443 DOI: 10.1074/mcp.M115.047977  1
2015 Fujita W, Gomes I, Devi LA. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities. British Journal of Pharmacology. 172: 375-87. PMID 24571499 DOI: 10.1111/bph.12663  1
2014 Gomes I, Gupta A, Bushlin I, Devi LA. Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function. Frontiers in Pharmacology. 5: 268. PMID 25520661 DOI: 10.3389/fphar.2014.00268  1
2014 Fujita W, Gomes I, Dove LS, Prohaska D, McIntyre G, Devi LA. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers. Biochemical Pharmacology. 92: 448-56. PMID 25261794 DOI: 10.1016/j.bcp.2014.09.015  1
2014 Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, et al. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86: 228-40. PMID 25107591 DOI: 10.1016/j.neuropharm.2014.07.016  1
2014 Fujita W, Gomes I, Devi LA. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10. British Journal of Pharmacology. 171: 4155-76. PMID 24916280 DOI: 10.1111/bph.12798  1
2014 Gupta A, Gomes I, Wardman J, Devi LA. Opioid receptor function is regulated by post-endocytic peptide processing. The Journal of Biological Chemistry. 289: 19613-26. PMID 24847082 DOI: 10.1074/jbc.M113.537704  1
2014 Toniolo EF, Maique ET, Ferreira WA, Heimann AS, Ferro ES, Ramos-Ortolaza DL, Miller L, Devi LA, Dale CS. Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. Peptides. 56: 125-31. PMID 24703998 DOI: 10.1016/j.peptides.2014.03.016  1
2014 Ferré S, Casadó V, Devi LA, Filizola M, Jockers R, Lohse MJ, Milligan G, Pin JP, Guitart X. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacological Reviews. 66: 413-34. PMID 24515647 DOI: 10.1124/pr.113.008052  1
2014 Yang L, Rozenfeld R, Wu D, Devi LA, Zhang Z, Cederbaum A. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radical Biology & Medicine. 68: 260-7. PMID 24398069 DOI: 10.1016/j.freeradbiomed.2013.12.026  0.4
2014 Matsumoto K, Narita M, Muramatsu N, Nakayama T, Misawa K, Kitajima M, Tashima K, Devi LA, Suzuki T, Takayama H, Horie S. Orally Active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mices Journal of Pharmacology and Experimental Therapeutics. 348: 383-392. PMID 24345467 DOI: 10.1124/jpet.113.208108  1
2014 Stockton SD, Devi LA. An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 88-103. PMID 24045585 DOI: 10.1038/npp.2013.227  1
2013 Gomes I, Aryal DK, Wardman JH, Gupta A, Gagnidze K, Rodriguiz RM, Kumar S, Wetsel WC, Pintar JE, Fricker LD, Devi LA. GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding. Proceedings of the National Academy of Sciences of the United States of America. 110: 16211-6. PMID 24043826 DOI: 10.1073/pnas.1312938110  1
2013 Gomes I, Fujita W, Gupta A, Saldanha SA, Saldanha AS, Negri A, Pinello CE, Eberhart C, Roberts E, Filizola M, Hodder P, Devi LA. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity. Proceedings of the National Academy of Sciences of the United States of America. 110: 12072-7. PMID 23818586 DOI: 10.1073/pnas.1222044110  1
2013 Gomes I, Fujita W, Chandrakala MV, Devi LA. Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse. Progress in Molecular Biology and Translational Science. 117: 207-65. PMID 23663971 DOI: 10.1016/B978-0-12-386931-9.00009-X  1
2013 Hernández-Gea V, Hilscher M, Rozenfeld R, Lim MP, Nieto N, Werner S, Devi LA, Friedman SL. Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. Journal of Hepatology. 59: 98-104. PMID 23485523 DOI: 10.1016/j.jhep.2013.02.016  0.4
2013 Gomes I, Gupta A, Devi LA. G-protein-coupled heteromers: regulation in disease. Methods in Enzymology. 521: 219-38. PMID 23351742 DOI: 10.1016/B978-0-12-391862-8.00012-0  1
2013 Narita M, Imai S, Nakamura A, Ozeki A, Asato M, Rahmadi M, Sudo Y, Hojo M, Uezono Y, Devi LA, Kuzumaki N, Suzuki T. Possible involvement of prolonging spinal μ-opioid receptor desensitization in the development of antihyperalgesic tolerance to μ-opioids under a neuropathic pain-like state Addiction Biology. 18: 614-622. PMID 21812868 DOI: 10.1111/j.1369-1600.2011.00354.x  1
2012 Bushlin I, Gupta A, Stockton SD, Miller LK, Devi LA. Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain. Plos One. 7: e49789. PMID 23272051 DOI: 10.1371/journal.pone.0049789  1
2012 Costantino CM, Gomes I, Stockton SD, Lim MP, Devi LA. Opioid receptor heteromers in analgesia. Expert Reviews in Molecular Medicine. 14: e9. PMID 22490239 DOI: 10.1017/erm.2012.5  1
2012 Costantino CM, Gupta A, Yewdall AW, Dale BM, Devi LA, Chen BK. Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells. Plos One. 7: e33961. PMID 22448282 DOI: 10.1371/journal.pone.0033961  1
2012 Rozenfeld R, Bushlin I, Gomes I, Tzavaras N, Gupta A, Neves S, Battini L, Gusella GL, Lachmann A, Ma'ayan A, Blitzer RD, Devi LA. Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. Plos One. 7: e29239. PMID 22235275 DOI: 10.1371/journal.pone.0029239  1
2012 Stockton SD, Devi LA. Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence. 121: 167-72. PMID 22115888 DOI: 10.1016/j.drugalcdep.2011.10.025  1
2012 Berg KA, Rowan MP, Gupta A, Sanchez TA, Silva M, Gomes I, McGuire BA, Portoghese PS, Hargreaves KM, Devi LA, Clarke WP. Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons. Molecular Pharmacology. 81: 264-72. PMID 22072818 DOI: 10.1124/mol.111.072702  1
2011 Abul-Husn NS, Annangudi SP, Ma'ayan A, Ramos-Ortolaza DL, Stockton SD, Gomes I, Sweedler JV, Devi LA. Chronic morphine alters the presynaptic protein profile: identification of novel molecular targets using proteomics and network analysis. Plos One. 6: e25535. PMID 22043286 DOI: 10.1371/journal.pone.0025535  1
2011 Miller LK, Hou X, Rodriguiz RM, Gagnidze K, Sweedler JV, Wetsel WC, Devi LA. Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord. Journal of Neurochemistry. 119: 1074-85. PMID 21972895 DOI: 10.1111/j.1471-4159.2011.07513.x  0.4
2011 Miller LK, Devi LA. The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacological Reviews. 63: 461-70. PMID 21752875 DOI: 10.1124/pr.110.003491  1
2011 Gupta A, Devi LA, Gomes I. Potentiation of μ-opioid receptor-mediated signaling by ketamine. Journal of Neurochemistry. 119: 294-302. PMID 21692801 DOI: 10.1111/j.1471-4159.2011.07361.x  1
2011 Rozenfeld R, Gupta A, Gagnidze K, Lim MP, Gomes I, Lee-Ramos D, Nieto N, Devi LA. AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. The Embo Journal. 30: 2350-63. PMID 21540834 DOI: 10.1038/emboj.2011.139  1
2011 Gomes I, Ijzerman AP, Ye K, Maillet EL, Devi LA. G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding. Molecular Pharmacology. 79: 1044-52. PMID 21415307 DOI: 10.1124/mol.110.070847  1
2011 Rozenfeld R, Devi LA. Exploring a role for heteromerization in GPCR signalling specificity. The Biochemical Journal. 433: 11-8. PMID 21158738 DOI: 10.1042/BJ20100458  0.4
2010 Gomes I, Dale CS, Casten K, Geigner MA, Gozzo FC, Ferro ES, Heimann AS, Devi LA. Hemoglobin-derived peptides as novel type of bioactive signaling molecules. The Aaps Journal. 12: 658-69. PMID 20811967 DOI: 10.1208/s12248-010-9217-x  1
2010 Ouimet T, Orng SV, Poras H, Gagnidze K, Devi LA, Fournié-Zaluski MC, Roques BP. Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay. The Journal of Biological Chemistry. 285: 34390-400. PMID 20807771 DOI: 10.1074/jbc.M110.120576  0.4
2010 LaRocca TJ, Schwarzkopf M, Altman P, Zhang S, Gupta A, Gomes I, Alvin Z, Champion HC, Haddad G, Hajjar RJ, Devi LA, Schecter AD, Tarzami ST. β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. Journal of Cardiovascular Pharmacology. 56: 548-59. PMID 20729750 DOI: 10.1097/FJC.0b013e3181f713fe  1
2010 Hipser C, Bushlin I, Gupta A, Gomes I, Devi LA. Role of antibodies in developing drugs that target G-protein-coupled receptor dimers. The Mount Sinai Journal of Medicine, New York. 77: 374-80. PMID 20687183 DOI: 10.1002/msj.20199  1
2010 Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, Lim M, Maillet E, Junek M, Cahill CM, Harkany T, Devi LA. Increased abundance of opioid receptor heteromers after chronic morphine administration. Science Signaling. 3: ra54. PMID 20647592 DOI: 10.1126/scisignal.2000807  1
2010 Khelashvili G, Dorff K, Shan J, Camacho-Artacho M, Skrabanek L, Vroling B, Bouvier M, Devi LA, George SR, Javitch JA, Lohse MJ, Milligan G, Neubig RR, Palczewski K, Parmentier M, et al. GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base. Bioinformatics (Oxford, England). 26: 1804-5. PMID 20501551 DOI: 10.1093/bioinformatics/btq264  1
2010 Morgan DJ, Wei S, Gomes I, Czyzyk T, Mzhavia N, Pan H, Devi LA, Fricker LD, Pintar JE. The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation. Journal of Neurochemistry. 113: 1275-84. PMID 20367757 DOI: 10.1111/j.1471-4159.2010.06706.x  1
2010 Rozenfeld R, Devi LA. Receptor heteromerization and drug discovery. Trends in Pharmacological Sciences. 31: 124-30. PMID 20060175 DOI: 10.1016/  0.4
2010 Ramos-Ortolaza DL, Bushlin I, Abul-Husn N, Annangudi SP, Sweedler J, Devi LA. Quantitative neuroproteomics of the synapse. Methods in Molecular Biology (Clifton, N.J.). 615: 227-46. PMID 20013213 DOI: 10.1007/978-1-60761-535-4_18  1
2010 Morón JA, Gullapalli S, Taylor C, Gupta A, Gomes I, Devi LA. Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 955-66. PMID 19956087 DOI: 10.1038/npp.2009.199  1
2010 Bushlin I, Rozenfeld R, Devi LA. Cannabinoid-opioid interactions during neuropathic pain and analgesia. Current Opinion in Pharmacology. 10: 80-6. PMID 19857996 DOI: 10.1016/j.coph.2009.09.009  1
2009 Abul-Husn NS, Bushlin I, Morón JA, Jenkins SL, Dolios G, Wang R, Iyengar R, Ma'ayan A, Devi LA. Systems approach to explore components and interactions in the presynapse. Proteomics. 9: 3303-15. PMID 19562802 DOI: 10.1002/pmic.200800767  1
2009 Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, Heimann AS, Ferro ES, Scarlata S, Fricker LD, Devi LA. Novel endogenous peptide agonists of cannabinoid receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 3020-9. PMID 19380512 DOI: 10.1096/fj.09-132142  1
2009 Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow ND, et al. Building a new conceptual framework for receptor heteromers. Nature Chemical Biology. 5: 131-4. PMID 19219011 DOI: 10.1038/nchembio0309-131  1
2008 Rodriguiz RM, Gadnidze K, Ragnauth A, Dorr N, Yanagisawa M, Wetsel WC, Devi LA. Animals lacking endothelin-converting enzyme-2 are deficient in learning and memory. Genes, Brain, and Behavior. 7: 418-26. PMID 21450041 DOI: 10.1111/j.1601-183X.2007.00365.x  1
2008 Décaillot FM, Rozenfeld R, Gupta A, Devi LA. Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proceedings of the National Academy of Sciences of the United States of America. 105: 16045-50. PMID 18836069 DOI: 10.1073/pnas.0804106105  1
2008 Gupta A, Heimann AS, Gomes I, Devi LA. Antibodies against G-protein coupled receptors: novel uses in screening and drug development. Combinatorial Chemistry & High Throughput Screening. 11: 463-7. PMID 18673273  1
2008 Gagnidze K, Sachchidanand, Rozenfeld R, Mezei M, Zhou MM, Devi LA. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2. Journal of Medicinal Chemistry. 51: 3378-87. PMID 18507370 DOI: 10.1021/jm7015478  1
2008 Charlton JJ, Allen PB, Psifogeorgou K, Chakravarty S, Gomes I, Neve RL, Devi LA, Greengard P, Nestler EJ, Zachariou V. Multiple actions of spinophilin regulate mu opioid receptor function. Neuron. 58: 238-47. PMID 18439408 DOI: 10.1016/j.neuron.2008.02.006  1
2008 Jenkins SL, Iyengar R, Diverse-Pierluissi MA, Chan AM, Devi LA, Sobie EA, Ting AT, Weinstein DC. Teaching resources. Using web-based discussion forums as a model of the peer-review process and a tool for assessment. Science Signaling. 1: tr2. PMID 18323015 DOI: 10.1126/stke.19tr2  1
2008 Iyengar R, Diverse-Pierluissi MA, Jenkins SL, Chan AM, Devi LA, Sobie EA, Ting AT, Weinstein DC. Inquiry learning. Integrating content detail and critical reasoning by peer review. Science (New York, N.Y.). 319: 1189-90. PMID 18309063 DOI: 10.1126/science.1149875  1
2008 Rozenfeld R, Devi LA. Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2311-22. PMID 18267983 DOI: 10.1096/fj.07-102731  0.4
2008 Gupta A, Rozenfeld R, Gomes I, Raehal KM, Décaillot FM, Bohn LM, Devi LA. Post-activation-mediated changes in opioid receptors detected by N-terminal antibodies. The Journal of Biological Chemistry. 283: 10735-44. PMID 18256033 DOI: 10.1074/jbc.M709454200  1
2007 Heimann AS, Gomes I, Dale CS, Pagano RL, Gupta A, de Souza LL, Luchessi AD, Castro LM, Giorgi R, Rioli V, Ferro ES, Devi LA. Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proceedings of the National Academy of Sciences of the United States of America. 104: 20588-93. PMID 18077343 DOI: 10.1073/pnas.0706980105  1
2007 Rozenfeld R, Abul-Husn NS, Gomez I, Devi LA. An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. Thescientificworldjournal. 7: 64-73. PMID 17982578 DOI: 10.1100/tsw.2007.219  0.4
2007 Rozenfeld R, Devi LA. Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 2455-65. PMID 17384143 DOI: 10.1096/fj.06-7793com  0.4
2007 Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Molecular Pharmacology. 71: 1222-32. PMID 17267664 DOI: 10.1124/mol.106.027763  1
2007 Harkany T, Guzmán M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends in Pharmacological Sciences. 28: 83-92. PMID 17222464 DOI: 10.1016/  1
2007 Gupta A, Décaillot FM, Gomes I, Tkalych O, Heimann AS, Ferro ES, Devi LA. Conformation state-sensitive antibodies to G-protein-coupled receptors. The Journal of Biological Chemistry. 282: 5116-24. PMID 17148456 DOI: 10.1074/jbc.M609254200  1
2007 Morón JA, Abul-Husn NS, Rozenfeld R, Dolios G, Wang R, Devi LA. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Molecular & Cellular Proteomics : McP. 6: 29-42. PMID 17028301 DOI: 10.1074/mcp.M600184-MCP200  0.4
2006 Gupta A, Devi LA. The use of receptor-specific antibodies to study G-protein-coupled receptors. The Mount Sinai Journal of Medicine, New York. 73: 673-81. PMID 16878273  1
2006 Décaillot FM, Che FY, Fricker LD, Devi LA. Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration. Journal of Molecular Neuroscience : Mn. 28: 277-84. PMID 16691015 DOI: 10.1385/JMN:28:3:277  1
2006 Rios C, Gomes I, Devi LA. μ opioid and CB1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neuritogenesis British Journal of Pharmacology. 148: 387-395. PMID 16682964 DOI: 10.1038/sj.bjp.0706757  1
2006 Breit A, Gagnidze K, Devi LA, Lagacé M, Bouvier M. Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling. Molecular Pharmacology. 70: 686-96. PMID 16682504 DOI: 10.1124/mol.106.022897  1
2006 Abul-Husn NS, Devi LA. Neuroproteomics of the synapse and drug addiction. The Journal of Pharmacology and Experimental Therapeutics. 318: 461-8. PMID 16644901 DOI: 10.1124/jpet.105.091520  0.4
2006 Chakraborty TR, Tkalych O, Nanno D, Garcia AL, Devi LA, Salton SR. Quantification of VGF- and pro-SAAS-derived peptides in endocrine tissues and the brain, and their regulation by diet and cold stress. Brain Research. 1089: 21-32. PMID 16631141 DOI: 10.1016/j.brainres.2006.02.124  1
2006 Gupta A, Décaillot FM, Devi LA. Targeting opioid receptor heterodimers: strategies for screening and drug development. The Aaps Journal. 8: E153-9. PMID 16584123 DOI: 10.1208/aapsj080118  1
2006 Pignatari GC, Rozenfeld R, Ferro ES, Oliveira L, Paiva AC, Devi LA. A role for transmembrane domains V and VI in ligand binding and maturation of the angiotensin II AT1 receptor. Biological Chemistry. 387: 269-76. PMID 16542148 DOI: 10.1515/BC.2006.036  0.4
2005 He JC, Gomes I, Nguyen T, Jayaram G, Ram PT, Devi LA, Iyengar R. The G alpha(o/i)-coupled cannabinoid receptor-mediated neurite outgrowth involves Rap regulation of Src and Stat3. The Journal of Biological Chemistry. 280: 33426-34. PMID 16046413 DOI: 10.1074/jbc.M502812200  1
2005 Morgan DJ, Mzhavia N, Peng B, Pan H, Devi LA, Pintar JE. Embryonic gene expression and pro-protein processing of proSAAS during rodent development. Journal of Neurochemistry. 93: 1454-62. PMID 15935061 DOI: 10.1111/j.1471-4159.2005.03138.x  1
2005 Fricker AD, Rios C, Devi LA, Gomes I. Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Brain Research. Molecular Brain Research. 138: 228-35. PMID 15925428 DOI: 10.1016/j.molbrainres.2005.04.016  1
2005 Pan H, Nanno D, Che FY, Zhu X, Salton SR, Steiner DF, Fricker LD, Devi LA. Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry. 44: 4939-48. PMID 15779921 DOI: 10.1021/bi047852m  1
2005 Iyengar R, Diverse-Pierluissi M, Weinstein D, Devi LA. Teaching resources. Cell signaling systems: a course for graduate students. Science's Stke : Signal Transduction Knowledge Environment. 2005: tr3. PMID 15687508 DOI: 10.1126/stke.2692005tr3  1
2005 Taylor C, Fricker AD, Devi LA, Gomes I. Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways. Cellular Signalling. 17: 549-57. PMID 15683730 DOI: 10.1016/j.cellsig.2004.12.007  1
2005 Jordan JD, He JC, Eungdamrong NJ, Gomes I, Ali W, Nguyen T, Bivona TG, Philips MR, Devi LA, Iyengar R. Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII. The Journal of Biological Chemistry. 280: 11413-21. PMID 15657046 DOI: 10.1074/jbc.M411521200  1
2004 Rios C, Gomes I, Devi LA. Interactions between δ opioid receptors and α2A- adrenoceptors Clinical and Experimental Pharmacology and Physiology. 31: 833-836. PMID 15566403 DOI: 10.1111/j.1440-1681.2004.04076.x  1
2004 Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proceedings of the National Academy of Sciences of the United States of America. 101: 5135-9. PMID 15044695 DOI: 10.1073/pnas.0307601101  1
2004 Wei S, Feng Y, Che FY, Pan H, Mzhavia N, Devi LA, McKinzie AA, Levin N, Richards WG, Fricker LD. Obesity and diabetes in transgenic mice expressing proSAAS. The Journal of Endocrinology. 180: 357-68. PMID 15012590 DOI: 10.1677/joe.0.1800357  1
2003 Filipovska J, Gomes I, Xu W, Chen C, Liu-Chen LY, Devi LA. Recombinant opioid receptors. Structure-function relationship. Methods in Molecular Medicine. 84: 185-203. PMID 12703324 DOI: 10.1385/1-59259-379-8:185  1
2003 Gomes I, Filipovska J, Devi LA. Opioid receptor oligomerization. Detection and functional characterization of interacting receptors. Methods in Molecular Medicine. 84: 157-83. PMID 12703323 DOI: 10.1385/1-59259-379-8:157  1
2003 Mzhavia N, Pan H, Che FY, Fricker LD, Devi LA. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. The Journal of Biological Chemistry. 278: 14704-11. PMID 12560336 DOI: 10.1074/jbc.M211242200  1
2002 Gomes I, Filipovska J, Jordan BA, Devi LA. Oligomerization of opioid receptors. Methods (San Diego, Calif.). 27: 358-65. PMID 12217652 DOI: 10.1016/S1046-2023(02)00094-4  1
2002 Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA, Fricker LD. Processing of proSAAS in neuroendocrine cell lines. The Biochemical Journal. 361: 67-76. PMID 11742530 DOI: 10.1042/0264-6021:3610067  1
Show low-probability matches.